Carl June of the Perelman School of Medicine is leading a study investigating the effects of cyclosporine on calming the immune systems of COVID-19 patients to prevent cytokine storms.
https://www.inquirer.com/business/drugs/cannabis-related-drug-fsd-fda-covid-19-immune-system-20200603.html Philadelphia Inquirer